ESC 365 - ECG and circulating biomarkers to stratify atrial fibrillation risk

ESC Premium Access

ECG and circulating biomarkers to stratify atrial fibrillation risk

Session: Atrial fibrillation and hypertension: implications for clinical practice

Topic: Hypertension, other

Speaker: Associate Professor G. Schillaci

Event: ESC Congress 2016

Congress Presentation

About the speaker

Associate Professor Giuseppe Schillaci

5 presentations

0 follower

3 more presentations in this session

Hypertensive phenotype and risk of atrial fibrillation

Speaker: Associate Professor M. Losi (Naples, IT)

Stroke prevention and anticoagulation in non valvular atrial fibrillation in hypertension

Speaker: Professor J. Camm (London, GB)

Drug treatment of hypertension to prevent atrial fibrillation and in patients with atrial fibrillation

Speaker: Doctor T. Aksnes (Oslo, NO)

Access the full session

Atrial fibrillation and hypertension: implications for clinical practice

Speakers: Associate Professor G. Schillaci, Associate Professor M. Losi, Professor J. Camm, Doctor T. Aksnes

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by